Victims set to recover $2.1 million — a small fraction of their losses
Court declines to overturn panel's conclusions in market manipulation case
Regulators adopt temporary measure to expand capital raising options
Misrepresentation allegations against pharma company and CEO dismissed
Regulators to boost fee transparency, explore enhanced retail access
Fraudster raised $1.2 million from investors in illegal distribution
BCSC returns nearly $40,000 to investors who lost much more
Abusive scheme exploited consultant exemption, regulator alleged
No evidence that executive tried to hide insider trades
Bulk of funds issuers raised went to consultants that quickly dumped shares